NCT00285727

Brief Summary

This is an 8 week study for patients who are currently taking antidepressant medication but not fully responding. Ropinirole CR would be taken in conjunction with current antidepressant medication. Patients come into the clinic once a week when starting on the medication and then once every other week for the remainder of the 8 weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2006

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 31, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 2, 2006

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2007

Completed
Last Updated

May 19, 2008

Status Verified

May 1, 2008

First QC Date

January 31, 2006

Last Update Submit

May 16, 2008

Conditions

Depressive Disorder, Major

Outcome Measures

Primary Outcomes (1)

  • HamD

Secondary Outcomes (1)

  • MADRS

Interventions

Ropinirole CRDRUG

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 to 65 years old
  • Currently experiencing major depression

You may not qualify if:

  • Known sensitivity to ropinirole
  • Significant medical conditions that would preclude safe participation in the study in the opinion of the investigators.
  • Significant abnormalities observed in screening laboratory evaluation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Stanford University School of Medicine

Stanford, California, 94305, United States

Location

Depression Research Clinic, Psychiatry Department, Stanford School of Medicine

Stanford, California, 9430, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Charles Debattista

    Depression Research Clinic, Psychiatry Department, Stanford School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 31, 2006

First Posted

February 2, 2006

Study Start

January 1, 2006

Study Completion

October 1, 2007

Last Updated

May 19, 2008

Record last verified: 2008-05

Locations

US(2)